Inadequate iron chelation increases the risk of life-threatening complications

60-70% of deaths in transfusion-dependent thalassemia patients are due to heart complications and disease.

Based on a total of 1,073 patients diagnosed with transfusion-dependent thalassemia before the age of 3.

If removal of NTBI can be achieved, complications of iron overload can be reduced or eliminated

Objectives of iron chelation therapy

Insert text here...

Depending on the organ, it can take a long time to reduce iron.

You are now leaving OurIronWill.comLinks to other websites are provided as a resource.
Please be aware that Chiesi Global Rare Diseases
is not responsible for content of those websites.
CONTINUE TO EXTERNAL SITESTAY ON CURRENT PAGE